Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Esophageal Neoplasms 4Weight Loss 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Malnutrition 2Intestinal Obstruction 2Duodenal Neoplasms 2Diarrhea 2Colorectal Neoplasms 2Carcinoid Tumor 2Adenoma, Islet Cell 2Acromegaly 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vomiting 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Serotonin Syndrome 1Sarcoma 1Rectal Neoplasms 1

Interventions

parathyroid hormone-related peptide (1-36) 2Musculoskeletal Manipulations 2Cisplatin 2niraparib 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1anlotinib 1adrenosterone 1Ultrasonography 1Thalidomide 1Sunitinib 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Paclitaxel 1Octreotide 1Melphalan 1Lutetium-177 1Lutetium 1Irinotecan 1Immune Checkpoint Inhibitors 1Hematologic Tests 1Gemcitabine 1Filgrastim 1Etoposide 1Eating 1Doxorubicin 1Diffusion 1Dexamethasone 1Dehydroepiandrosterone 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endocrine System Diseases × Octreotide × Clear all
NCT02385617 2023-11-27

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

St. James's Hospital, Ireland

Phase NA Completed
20 enrolled
Gastrointestinal

Endocrine System Diseases, Esophageal Neoplasms, Stomach Neoplasms, Weight Loss, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡